California Technology Assessment Forum California Technology Assessment Forum http://www.ctaf.org/ 2008-07-06T15:27:40+00:00 FeedCreator 1.7.2-ppt (info@mypapit.net) Use of Genetic Testing to Guide the Initiation of Warfarin Therapy 2008-03-27T20:00:00+00:00 2008-03-27T20:00:00+00:00 http://www.ctaf.org/content/assessment/detail/814/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on March 5, 2008. It was recommended that the use of genetic testing to guide initial warfarin dosing does not meet Technology Assessment Criteria 3 through 5 for safety, effectiveness and improvement in health outcomes. Human Papillomavirus Testing for Primary Cervical Cancer Screening 2008-03-27T19:15:00+00:00 2008-03-27T19:15:00+00:00 http://www.ctaf.org/content/assessment/detail/813/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on March 5, 2008. It was recommended that the use of Human Papillomavirus Testing in Cervical Cancer Screening does not meet technology assessment criteria 3 or 4 for improving net health outcomes and being as effective as any established alternatives. Analysis Calls For Medical Device Information To Better Serve Patients And Doctors 2008-02-01T22:15:00+00:00 2008-02-01T22:15:00+00:00 http://www.ctaf.org/content/ctaf_news/detail/798/ California Technology Assessment Forum The approval process for medical devices does not involve the same rigorous review used for pharmaceuticals, and this needs to change in order to improve health outcomes, say researchers from the University of California, San Francisco. Drug Eluting Stents: An Update With a Focus on Safety 2007-12-04T00:00:00+00:00 2007-12-04T00:00:00+00:00 http://www.ctaf.org/content/assessment/detail/778/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on February 28, 2007. The panel determined that: Drug-eluting stents be implanted only in patients who meet current FDA labeling criteria. Microprocessor-Controlled Prosthetic Knees 2007-12-03T23:45:00+00:00 2007-12-03T23:45:00+00:00 http://www.ctaf.org/content/assessment/detail/777/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on October 17, 2007. It was recommended that use of a C-Leg microprocessor-controlled prosthetic knee in otherwise healthy, active K3-K4 community ambulating adults with a trans-femoral amputation from a non-vascular cause for whom this prosthesis can be fit and programmed by a qualified prosthetist trained to do so, meets CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes. Use of the Merci Retriever for the Emergent Treatment of Acute Ischemic Stroke 2007-11-15T21:15:00+00:00 2007-11-15T21:15:00+00:00 http://www.ctaf.org/content/assessment/detail/770/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on October 17, 2007. It was recommended that the use of the Merci retriever does not meet Technology Assessment Criteria 2 through 5 for safety, effectiveness and improvement in health outcomes when used to treat acute ischemic stroke. Metal on Metal Total Hip Resurfacing as an Alternative to Total Hip Arthroplasty 2007-11-15T21:15:00+00:00 2007-11-15T21:15:00+00:00 http://www.ctaf.org/content/assessment/detail/769/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on October 17, 2007. It was recommended that metal on metal hip resurfacing using the BHR or Cormet 2000 devices does not meet CTAF criteria 2-5 for safety, efficacy and improvement in health outcomes. Computed Tomographic Angiography in the Diagnosis of Coronary Artery Stenosis and for the Evaluation of Acute Chest Pain 2007-12-06T05:00:00+00:00 2007-12-06T05:00:00+00:00 http://www.ctaf.org/content/assessment/detail/768/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on October 17, 2007. It was recommended that CTA as a substitute for coronary angiography for the diagnosis of coronary artery stenosis does not meet the CTAF TA criteria 2 through 5 for safety, efficacy and improvement in health outcomes. CTA in the evaluation of acute chest pain in the ER does not meet CTAF TA criteria 2 through 5 for safety, efficacy and improvement in health outcomes. CTAF Meeting 2007-09-12T17:15:00+00:00 2007-09-12T17:15:00+00:00 http://www.ctaf.org/content/calendar/detail/747/ California Technology Assessment Forum CTAF Meeting 2007-09-12T17:15:00+00:00 2007-09-12T17:15:00+00:00 http://www.ctaf.org/content/calendar/detail/746/ California Technology Assessment Forum CTAF Meeting 2007-09-12T17:15:00+00:00 2007-09-12T17:15:00+00:00 http://www.ctaf.org/content/calendar/detail/745/ California Technology Assessment Forum /files/745_image_Final_Mtg_Summary03_05_08.pdf Percutaneous Radiofrequency Neurotomy for Treatment of Chronic Pain from the Upper Cervical (C2-3) Spine 2007-08-31T18:00:00+00:00 2007-08-31T18:00:00+00:00 http://www.ctaf.org/content/assessment/detail/742/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on June 20, 2007. It was recommended that the use of Percutaneous Radiofrequency Neurotomy does not meet TA criteria 2 through 5 for safety, effectiveness and improvement in health outcomes for the treatment of chronic upper cervical (C2-3) neck pain or headache. Fecal Immunochemical Testing (FIT) to Screen for Colorectal Cancer 2007-08-31T18:00:00+00:00 2007-08-31T18:00:00+00:00 http://www.ctaf.org/content/assessment/detail/741/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on June 20, 2007. It was recommended that use of Fecal Immunochemical Tests (FIT) as a screening modality for colorectal cancer annually in individuals for whom screening is clinically appropriate and recommended meets CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes Peripheral Unltrafiltration for the Management of Acute Decompensated Heart Failure 2007-08-31T18:00:00+00:00 2007-08-31T18:00:00+00:00 http://www.ctaf.org/content/assessment/detail/740/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on June 20, 2007. It was recommended that the use of peripheral ultrafiltration does not meet Technology Assessment Criterion 3, 4 and 5 for safety, effectiveness and improvement in health outcomes when used to treat acute decompensated heart failure. Extracorporeal Shock-wave Therapy (ESWT) for Plantar Fasciitis not Responding to Conservative Therapy 2007-08-31T17:45:00+00:00 2007-08-31T17:45:00+00:00 http://www.ctaf.org/content/assessment/detail/739/ California Technology Assessment Forum This topic was reviewed by the California Technology Assessment Forum on June 20, 2007. It was recommended that the use of ESWT for the treatment of plantar fasciitis does not meet technology assessment criteria 3, 4, or 5 for safety, effectiveness, and improvement in health outcomes.